ACE2 and COVID-19: In COVID-19, increased expression of ACE2 in obese subjects contributes to activation of the NLRP3 inflammasome and hyperproduction of pro-inflammatory cytokines that are superimposed on the chronic inflammatory state to promote the cytokine shock characteristic of severe COVID.